Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat

Phosphorothioated antisense oligodeoxynucleotide (ASODN) targeted to angiotensinogen mRNA was administered intracerebroventricularly in spontaneously hypertensive rats to test whether angiotensinogen reduction would lower their hypertensive blood pressures. The ASODN lowers hypertensive blood pressu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 1995-03, Vol.25 (3), p.314-319
Hauptverfasser: Wielbo, Donna, Sernia, Conrad, Gyurko, Robert, Phillips, M. Ian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 319
container_issue 3
container_start_page 314
container_title Hypertension (Dallas, Tex. 1979)
container_volume 25
creator Wielbo, Donna
Sernia, Conrad
Gyurko, Robert
Phillips, M. Ian
description Phosphorothioated antisense oligodeoxynucleotide (ASODN) targeted to angiotensinogen mRNA was administered intracerebroventricularly in spontaneously hypertensive rats to test whether angiotensinogen reduction would lower their hypertensive blood pressures. The ASODN lowers hypertensive blood pressures to normotensive levels in spontaneously hypertensive rats; sense oligodeoxynucleotide had no effect. Administration of phosphorothioated ASODN produced a prolonged duration of lowered blood pressure. Injections of ASODN at the same dose that decreased hypertension when administered centrally did not result in blood pressure decreases when administered intra-arterially. Furthermore, angiotensinogen production was decreased in the brain stem and significantly decreased in the hypothalamus of the ASODN-treated rats (P < .05), supporting the concept of centrally mediated regulation of hypertension by an overactive brain angiotensin system. To determine the distribution of centrally administered oligodeoxynucleotides, fluorescein isothiocyanate-conjugated oligodeoxynucleotides were injected directly into the lateral ventricles. One hour later, oligodeoxynucleotides were distributed throughout the lateral and third ventricles, with tissue and cellular uptake observed in discrete cells at the injection site. This indicates that the oligodeoxynucleotides are taken up rapidly by brain cells and that they permeate the areas surrounding brain nuclei involved in central blood pressure regulation and volume homeostasis. The results confirm and extend our previous study with phosphodiester ASODN and show that phosphorothioation modification increases the duration of the response and is taken up in vivo. We conclude that with modification, ASODN inhibition of angiotensinogen mRNA translation can be used for a prolonged, profound decrease in mean arterial pressure in the spontaneously hypertensive rat through a central mechanism. (Hypertension. 1995;25:314-319.)
doi_str_mv 10.1161/01.HYP.25.3.314
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77160134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14746970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4343-ce27ff92c2d09570171ba9b7dfeeeafcc03620ab0ee4f5a9b26299d37237b00b3</originalsourceid><addsrcrecordid>eNpdkU2LFDEQhoMo6zh69iQ0It66tyofnclxWdRZWVD8AD2FdE-F6bUnPSZpl_n3ZphhEXMpqt4nVcVbjL1EaBBbvARs1j8_N1w1ohEoH7EFKi5rqVrxmC0AjawN4o-n7FlKdwAopdQX7EKvtNJKLdjHq5CHRCFRdRO2QzfkYQrV5Kv1YU8xF-GYD6HKW6q-7qeQXaBpTuPhH-IPVV9cfs6eeDcmenGOS_b9_btv1-v69tOHm-ur27qXQoq6J669N7znGzBKA2rsnOn0xhOR830PouXgOiCSXhWFt9yYjdBc6A6gE0v29tR3H6ffM6Vsd0PqaRxPm1mtsQUso5bs9X_g3TTHUHazHBRvW66hQJcnqI9TSpG83cdh5-LBItijxRbQFostV1bYYnH58ercdu52tHngz54W_c1Zd6l3o48u9EN6wEQ5wUodB8sTdj-NmWL6Nc73FO2W3Ji3FsqTvF3VaEyBS1YfS0L8BVVdk2M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205266270</pqid></control><display><type>article</type><title>Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Wielbo, Donna ; Sernia, Conrad ; Gyurko, Robert ; Phillips, M. Ian</creator><creatorcontrib>Wielbo, Donna ; Sernia, Conrad ; Gyurko, Robert ; Phillips, M. Ian</creatorcontrib><description>Phosphorothioated antisense oligodeoxynucleotide (ASODN) targeted to angiotensinogen mRNA was administered intracerebroventricularly in spontaneously hypertensive rats to test whether angiotensinogen reduction would lower their hypertensive blood pressures. The ASODN lowers hypertensive blood pressures to normotensive levels in spontaneously hypertensive rats; sense oligodeoxynucleotide had no effect. Administration of phosphorothioated ASODN produced a prolonged duration of lowered blood pressure. Injections of ASODN at the same dose that decreased hypertension when administered centrally did not result in blood pressure decreases when administered intra-arterially. Furthermore, angiotensinogen production was decreased in the brain stem and significantly decreased in the hypothalamus of the ASODN-treated rats (P &lt; .05), supporting the concept of centrally mediated regulation of hypertension by an overactive brain angiotensin system. To determine the distribution of centrally administered oligodeoxynucleotides, fluorescein isothiocyanate-conjugated oligodeoxynucleotides were injected directly into the lateral ventricles. One hour later, oligodeoxynucleotides were distributed throughout the lateral and third ventricles, with tissue and cellular uptake observed in discrete cells at the injection site. This indicates that the oligodeoxynucleotides are taken up rapidly by brain cells and that they permeate the areas surrounding brain nuclei involved in central blood pressure regulation and volume homeostasis. The results confirm and extend our previous study with phosphodiester ASODN and show that phosphorothioation modification increases the duration of the response and is taken up in vivo. We conclude that with modification, ASODN inhibition of angiotensinogen mRNA translation can be used for a prolonged, profound decrease in mean arterial pressure in the spontaneously hypertensive rat through a central mechanism. (Hypertension. 1995;25:314-319.)</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.25.3.314</identifier><identifier>PMID: 7875755</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Angiotensinogen - biosynthesis ; Angiotensinogen - genetics ; Animals ; Antisense Elements (Genetics) - genetics ; Arterial hypertension. Arterial hypotension ; Base Sequence ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure - drug effects ; Brain - physiology ; Cardiology. Vascular system ; Experimental diseases ; Fluorescein-5-isothiocyanate ; Hypertension - genetics ; Hypertension - prevention &amp; control ; Injections, Intraventricular ; Male ; Medical sciences ; Molecular Sequence Data ; Oligonucleotides, Antisense - pharmacology ; Rats ; Rats, Inbred SHR ; RNA, Messenger - genetics</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1995-03, Vol.25 (3), p.314-319</ispartof><rights>1995 American Heart Association, Inc.</rights><rights>1995 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Mar 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4343-ce27ff92c2d09570171ba9b7dfeeeafcc03620ab0ee4f5a9b26299d37237b00b3</citedby><cites>FETCH-LOGICAL-c4343-ce27ff92c2d09570171ba9b7dfeeeafcc03620ab0ee4f5a9b26299d37237b00b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3674,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3444850$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7875755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wielbo, Donna</creatorcontrib><creatorcontrib>Sernia, Conrad</creatorcontrib><creatorcontrib>Gyurko, Robert</creatorcontrib><creatorcontrib>Phillips, M. Ian</creatorcontrib><title>Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Phosphorothioated antisense oligodeoxynucleotide (ASODN) targeted to angiotensinogen mRNA was administered intracerebroventricularly in spontaneously hypertensive rats to test whether angiotensinogen reduction would lower their hypertensive blood pressures. The ASODN lowers hypertensive blood pressures to normotensive levels in spontaneously hypertensive rats; sense oligodeoxynucleotide had no effect. Administration of phosphorothioated ASODN produced a prolonged duration of lowered blood pressure. Injections of ASODN at the same dose that decreased hypertension when administered centrally did not result in blood pressure decreases when administered intra-arterially. Furthermore, angiotensinogen production was decreased in the brain stem and significantly decreased in the hypothalamus of the ASODN-treated rats (P &lt; .05), supporting the concept of centrally mediated regulation of hypertension by an overactive brain angiotensin system. To determine the distribution of centrally administered oligodeoxynucleotides, fluorescein isothiocyanate-conjugated oligodeoxynucleotides were injected directly into the lateral ventricles. One hour later, oligodeoxynucleotides were distributed throughout the lateral and third ventricles, with tissue and cellular uptake observed in discrete cells at the injection site. This indicates that the oligodeoxynucleotides are taken up rapidly by brain cells and that they permeate the areas surrounding brain nuclei involved in central blood pressure regulation and volume homeostasis. The results confirm and extend our previous study with phosphodiester ASODN and show that phosphorothioation modification increases the duration of the response and is taken up in vivo. We conclude that with modification, ASODN inhibition of angiotensinogen mRNA translation can be used for a prolonged, profound decrease in mean arterial pressure in the spontaneously hypertensive rat through a central mechanism. (Hypertension. 1995;25:314-319.)</description><subject>Angiotensinogen - biosynthesis</subject><subject>Angiotensinogen - genetics</subject><subject>Animals</subject><subject>Antisense Elements (Genetics) - genetics</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure - drug effects</subject><subject>Brain - physiology</subject><subject>Cardiology. Vascular system</subject><subject>Experimental diseases</subject><subject>Fluorescein-5-isothiocyanate</subject><subject>Hypertension - genetics</subject><subject>Hypertension - prevention &amp; control</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>RNA, Messenger - genetics</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU2LFDEQhoMo6zh69iQ0It66tyofnclxWdRZWVD8AD2FdE-F6bUnPSZpl_n3ZphhEXMpqt4nVcVbjL1EaBBbvARs1j8_N1w1ohEoH7EFKi5rqVrxmC0AjawN4o-n7FlKdwAopdQX7EKvtNJKLdjHq5CHRCFRdRO2QzfkYQrV5Kv1YU8xF-GYD6HKW6q-7qeQXaBpTuPhH-IPVV9cfs6eeDcmenGOS_b9_btv1-v69tOHm-ur27qXQoq6J669N7znGzBKA2rsnOn0xhOR830PouXgOiCSXhWFt9yYjdBc6A6gE0v29tR3H6ffM6Vsd0PqaRxPm1mtsQUso5bs9X_g3TTHUHazHBRvW66hQJcnqI9TSpG83cdh5-LBItijxRbQFostV1bYYnH58ercdu52tHngz54W_c1Zd6l3o48u9EN6wEQ5wUodB8sTdj-NmWL6Nc73FO2W3Ji3FsqTvF3VaEyBS1YfS0L8BVVdk2M</recordid><startdate>199503</startdate><enddate>199503</enddate><creator>Wielbo, Donna</creator><creator>Sernia, Conrad</creator><creator>Gyurko, Robert</creator><creator>Phillips, M. Ian</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>199503</creationdate><title>Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat</title><author>Wielbo, Donna ; Sernia, Conrad ; Gyurko, Robert ; Phillips, M. Ian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4343-ce27ff92c2d09570171ba9b7dfeeeafcc03620ab0ee4f5a9b26299d37237b00b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Angiotensinogen - biosynthesis</topic><topic>Angiotensinogen - genetics</topic><topic>Animals</topic><topic>Antisense Elements (Genetics) - genetics</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure - drug effects</topic><topic>Brain - physiology</topic><topic>Cardiology. Vascular system</topic><topic>Experimental diseases</topic><topic>Fluorescein-5-isothiocyanate</topic><topic>Hypertension - genetics</topic><topic>Hypertension - prevention &amp; control</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>RNA, Messenger - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wielbo, Donna</creatorcontrib><creatorcontrib>Sernia, Conrad</creatorcontrib><creatorcontrib>Gyurko, Robert</creatorcontrib><creatorcontrib>Phillips, M. Ian</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wielbo, Donna</au><au>Sernia, Conrad</au><au>Gyurko, Robert</au><au>Phillips, M. Ian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1995-03</date><risdate>1995</risdate><volume>25</volume><issue>3</issue><spage>314</spage><epage>319</epage><pages>314-319</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Phosphorothioated antisense oligodeoxynucleotide (ASODN) targeted to angiotensinogen mRNA was administered intracerebroventricularly in spontaneously hypertensive rats to test whether angiotensinogen reduction would lower their hypertensive blood pressures. The ASODN lowers hypertensive blood pressures to normotensive levels in spontaneously hypertensive rats; sense oligodeoxynucleotide had no effect. Administration of phosphorothioated ASODN produced a prolonged duration of lowered blood pressure. Injections of ASODN at the same dose that decreased hypertension when administered centrally did not result in blood pressure decreases when administered intra-arterially. Furthermore, angiotensinogen production was decreased in the brain stem and significantly decreased in the hypothalamus of the ASODN-treated rats (P &lt; .05), supporting the concept of centrally mediated regulation of hypertension by an overactive brain angiotensin system. To determine the distribution of centrally administered oligodeoxynucleotides, fluorescein isothiocyanate-conjugated oligodeoxynucleotides were injected directly into the lateral ventricles. One hour later, oligodeoxynucleotides were distributed throughout the lateral and third ventricles, with tissue and cellular uptake observed in discrete cells at the injection site. This indicates that the oligodeoxynucleotides are taken up rapidly by brain cells and that they permeate the areas surrounding brain nuclei involved in central blood pressure regulation and volume homeostasis. The results confirm and extend our previous study with phosphodiester ASODN and show that phosphorothioation modification increases the duration of the response and is taken up in vivo. We conclude that with modification, ASODN inhibition of angiotensinogen mRNA translation can be used for a prolonged, profound decrease in mean arterial pressure in the spontaneously hypertensive rat through a central mechanism. (Hypertension. 1995;25:314-319.)</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>7875755</pmid><doi>10.1161/01.HYP.25.3.314</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 1995-03, Vol.25 (3), p.314-319
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_77160134
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Angiotensinogen - biosynthesis
Angiotensinogen - genetics
Animals
Antisense Elements (Genetics) - genetics
Arterial hypertension. Arterial hypotension
Base Sequence
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure - drug effects
Brain - physiology
Cardiology. Vascular system
Experimental diseases
Fluorescein-5-isothiocyanate
Hypertension - genetics
Hypertension - prevention & control
Injections, Intraventricular
Male
Medical sciences
Molecular Sequence Data
Oligonucleotides, Antisense - pharmacology
Rats
Rats, Inbred SHR
RNA, Messenger - genetics
title Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A57%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antisense%20Inhibition%20of%20Hypertension%20in%20the%20Spontaneously%20Hypertensive%20Rat&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Wielbo,%20Donna&rft.date=1995-03&rft.volume=25&rft.issue=3&rft.spage=314&rft.epage=319&rft.pages=314-319&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.25.3.314&rft_dat=%3Cproquest_cross%3E14746970%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205266270&rft_id=info:pmid/7875755&rfr_iscdi=true